How to wrap a stuffy christmas holiday gift wrapping tutorial bear paper ...

Photoshop CS5 tutorial showing how to make a sheet of crumpled paper from scratch using simple techniques. Dietitians say you shouldn't take these vitamins in the morning Trump’s new warning and ...

Pfizer has underperformed the market in each of the past three years. The stock is doing well of late as investors have been turning to safer investments amid uncertainty. Pfizer has been struggling ...

Pfizer is making more changes to its layout in California by stepping away from a South San Francisco office site that used to host the headquarters for its 2022-acquired Global Blood Therapeutics.

Pfizer (PFE) is preparing to shut a research site and an office location in South San Francisco at the end of April, signaling a notable pullback from the Bay Area’s flagship biotech space, the San ...

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see pushback from the government following studies done on the vaccine. "What ...

Pfizer is behind Eli Lilly and Novo Nordisk in the GLP-1 race, but long-term investors shouldn't count the company out. GLP-1 drugs have seen strong consumer demand. Eli Lilly's industry-leading GLP-1 ...

Pfizer (PFE) is trading at $26.59 with shares up 9.31% year-to-date, while Guggenheim raised its price target to $36 with a Buy rating versus Wall Street’s cautious $28.14 consensus. Pfizer’s oncology ...

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though fewer-than-expected cases in a study made it hard to determine how well it works on a ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: An illustration photo shows a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine from Skippack ...

Results from a phase 3 clinical trial of Pfizer’s Lyme disease vaccine candidate found it was more than 70 percent effective at preventing the illness. Participants in Pfizer’s trial received four ...

Pfizer started 2026 on a high note despite ongoing skepticism from retail investors. Its key anti-cancer drugs, Padcev, Lorbrena, and Talzenna, showed strong performance in Q4. Accordingly, sales of ...